4.7 Article

Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Performance of High Mobility Protein Group 1 and Interleukin-6 as Predictors of Outcomes Resulting from Variceal Bleeding in Patients with Advanced Chronic Liver Disease

Camilla Dos Santos Pinheiro et al.

Summary: The study evaluated the performance of HMG1 and IL-6 as predictors of AKI, infection, and death in cirrhotic patients with variceal bleeding. HMG1 was found to be associated with AKI and infection, while IL-6 showed good performance in infection and death outcomes. This data will be useful for comparisons and potential future validations.

INFLAMMATION (2022)

Article Urology & Nephrology

High mobility group box 1 and homocysteine as preprocedural predictors for contrast-induced acute kidney injury after percutaneous coronary artery intervention

Changhua Mo et al.

Summary: HMGB1 and Hcy play important roles in CI-AKI and can serve as preprocedural predictors in PCI patients. They are significantly correlated with the development of CI-AKI and are independent predictors for CI-AKI. HMGB1 and Hcy have predictive values for CI-AKI.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

Article Hematology

Early biochemical markers in the assessment of acute kidney injury in children after cardiac surgery

Slobodan Galic et al.

Summary: The study evaluated biochemical markers in children's early onset of acute kidney injury after congenital heart defect surgery, finding that plasma CysC and urinary NGAL could reliably predict the development of kidney injury.

THERAPEUTIC APHERESIS AND DIALYSIS (2022)

Article Biology

Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury

Taro Miyagawa et al.

Summary: The study found that in acute kidney injury (AKI), the absence of both RAGE and sRAGE leads to more severe renal damage, while the addition of sRAGE can inhibit hypoxia-induced inflammation and promote cell viability in tubular epithelial cells.

BIOLOGY OPEN (2022)

Article Biotechnology & Applied Microbiology

Combination therapy of Ulinastatin with Thrombomodulin alleviates endotoxin (LPS)-induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway

Xiong Zhang et al.

Summary: Our study reports an effective two-drug combination therapy using urine-derived Ulinastatin and Thrombomodulin to treat liver and kidney injury induced by endotoxin. The combination therapy significantly improved pathological structures and functional injuries, and increased survival rates in endotoxic rats.

BIOENGINEERED (2022)

Article Cell Biology

Release of HMGB1 in Podocytes Exacerbates Lipopolysaccharide-Induced Acute Kidney Injury

Zhao Gao et al.

Summary: The study found that the expression of HMGB1 increased in the kidneys of AKI mice, and HMGB1 in LPS-challenged podocytes also increased. Knockdown of HMGB1 attenuated LPS-induced podocyte injury and triggered EMT in TECs. Exposure to HMGB1 resulted in increased mitochondrial damage and apoptosis in HK-2 cells.

MEDIATORS OF INFLAMMATION (2021)

Article Physiology

Osthole Blocks HMGB1 Release From the Nucleus and Confers Protective Effects Against Renal Ischemia-Reperfusion Injury

Qing Dai et al.

Summary: Renal ischemia-reperfusion (IR) injury is a major cause of kidney injury, and its clinical treatment is challenging. Research has shown that osthole can protect the kidneys by inhibiting inflammatory responses and reducing cell apoptosis. This protective effect has drawn significant attention in recent years.

FRONTIERS IN PHYSIOLOGY (2021)

Article Gastroenterology & Hepatology

Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure

Praveen Jha et al.

Summary: This study found that serum cystatin C is a better early predictor of AKI in patients with ACLF compared to traditional markers like creatinine. Cystatin C may serve as an early marker for new-onset AKI in hospitalized ACLF patients.

INDIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Integrative & Complementary Medicine

Correlation and Diagnostic Value of Serum Cys-C, RBP4, and NGAL with the Condition of Patients with Traumatic Acute Kidney Injury

Zufeng Ye et al.

Summary: There is a lack of specific biomarkers for early and accurate diagnosis of Acute Kidney Injury (AKI), leading to renal function deterioration and potential death. Studies indicate that Cys-C, RBP, and NGAL can be used for early AKI diagnosis. The research findings show significant differences in serum markers among AKI patients and healthy individuals, demonstrating their diagnostic value in assessing traumatic AKI patients.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)

Article Medicine, General & Internal

Assessment of 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients

Yating Hou et al.

Summary: The study in the ICU patients found that serum cystatin C (CysC) had the best performance in predicting AKI and severe AKI. Combinations of CysC with N-acetyl-beta-d-glucosaminidase-to-creatinine ratio (NAG/Cr) or lactic acid (LAC) were effective for predicting AKI and severe AKI respectively. Additionally, CysC combined with clinical markers such as Acute Physiology and Chronic Health Evaluation (APACHE) II score or Multiple Organ Dysfunction Score (MODS) showed good predictive abilities for AKI and severe AKI.

JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2021)

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment

Giacomo Zaccherini et al.

Summary: ACLF is a life-threatening condition characterized by sudden worsening of clinical outcomes in patients with cirrhosis or chronic liver disease. Different definitions, diagnostic criteria, and treatments have been proposed, with supportive therapy and liver transplantation showing efficacy in managing ACLF. Future studies on mechanistic treatments to improve patient survival are needed.

JHEP REPORTS (2021)

Article Gastroenterology & Hepatology

High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

Quan Chen et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2020)

Review Medicine, Research & Experimental

HMGB1 in kidney diseases

Zhi Zhao et al.

LIFE SCIENCES (2020)

Article Cell Biology

Evaluation of the Biomarkers HMGB1 and IL-6 as Predictors of Mortality in Cirrhotic Patients with Acute Kidney Injury

Celio Geraldo de Oliveira Gomes et al.

MEDIATORS OF INFLAMMATION (2020)

Article Cell Biology

Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer

Rui Kang et al.

CELL RESEARCH (2017)

Article Medicine, General & Internal

Risk Factors and Outcomes of Acute Kidney Injury in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Wei Yuan et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)

Article Urology & Nephrology

Urinary Biomarkers at the Time of AKI Diagnosis as Predictors of Progression of AKI among Patients with Acute Cardiorenal Syndrome

Chunbo Chen et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Gastroenterology & Hepatology

Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure

Junjun Cai et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)

Review Pharmacology & Pharmacy

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases

Qingjie Chen et al.

ACTA PHARMACEUTICA SINICA B (2016)

Article Medicine, Research & Experimental

HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients

JooYeon Jhun et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2015)

Article Cell Biology

The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines

Ruo-Chan Chen et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)

Article Gastroenterology & Hepatology

Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure

Zhi-Hong Wan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Immunology

Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

Emilie Venereau et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Article Cardiac & Cardiovascular Systems

Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron Damage A Multicenter Prospective Cohort Study

Thomas L. Nickolas et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Article Urology & Nephrology

Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury

Michael A. Ferguson et al.

KIDNEY INTERNATIONAL (2010)